Citius Oncology Inc (CTOR)

02:09 AM

Should I hold or sell Citius Oncology Inc. stock in 2025Market Forecast Picks That Work - jammulinksnews.com

02:09 AM

01:04 AM

How does Citius Oncology Inc. compare to its industry peersAchieve breakthrough results with expert guidance - jammulinksnews.com

01:04 AM

12:31 PM

What is the risk reward ratio of investing in Citius Oncology Inc. stockMassive stock growth - jammulinksnews.com

12:31 PM

Jul 27, 2025

What are the latest earnings results for Citius Oncology Inc.Discover stocks with explosive upside potential - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

What is Citius Oncology Inc. company’s growth strategyCapitalize on market momentum for profits - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

Citius Oncology Inc. Stock Support and Resistance Levels You Should KnowVerified Return Tips - Metal.it

Jul 27, 2025

Jul 27, 2025

Does Citius Oncology Inc. stock perform well during market downturnsInvest smarter with data-backed insights - jammulinksnews.com

Jul 27, 2025

Jul 25, 2025

Is Citius Oncology Inc. a good long term investmentExceptional trading performance - Autocar Professional

Jul 25, 2025

Jul 25, 2025

What drives Citius Oncology Inc. stock priceDynamic growth stocks - Autocar Professional

Jul 25, 2025

Jul 24, 2025

Citius Oncology Announces Closing of $9.0 Million Public Offering - StreetInsider

Jul 24, 2025

Jul 23, 2025

Citius Oncology Inc. Stock Analysis and ForecastMarket-leading capital gains - Autocar Professional

Jul 23, 2025

Jul 22, 2025

What analysts say about Citius Oncology Inc. stockFree Wealth Management Insights - jammulinksnews.com

Jul 22, 2025

Jul 18, 2025

Citius Oncology shares rise 1.31% after-hours after closing a $9.0 million public offering. - AInvest

Jul 18, 2025

Jul 18, 2025

Should I buy Citius Oncology Inc. stock before earningsShort Term High Return Strategy - Newser

Jul 18, 2025

Jul 18, 2025

Citius Oncology Completes $9M Public Offering - TipRanks

Jul 18, 2025

Jul 17, 2025

Citius Oncology launches $15M equity and warrant offering; shares down - MSN

Jul 17, 2025

Jul 17, 2025

Citius Oncology closes $9 million public offering to support LYMPHIR - Investing.com Australia

Jul 17, 2025

Jul 17, 2025

Citius Oncology closes $9 million public offering to support LYMPHIR By Investing.com - Investing.com Nigeria

Jul 17, 2025

Jul 17, 2025

Citius Oncology Raises $9M in Public Offering for LYMPHIR Commercialization - AInvest

Jul 17, 2025

Jul 17, 2025

Citius Oncology Announces Closing Of $9.0 Million Public Offering - Barchart.com

Jul 17, 2025

Jul 17, 2025

Citius Oncology Announces Pricing Of $9M "Reasonable Best-Efforts" Public Offering Of 6,818,182 Shares Of Common Stock And Warrants To Purchase Shares Of Common Stock At A Public Offering Price Of $1.32 Per Share - 富途牛牛

Jul 17, 2025

Jul 16, 2025

Citius Pharmaceuticals shares fall 1.34% after-hours following Citius Oncology's public offering. - AInvest

Jul 16, 2025

Jul 16, 2025

Citius Oncology’s Chances: Time to Invest? - StocksToTrade

Jul 16, 2025

Jul 16, 2025

Citius Oncology Announces Pricing of $9.0 Million Public Offering - Finansavisen

Jul 16, 2025

Jul 16, 2025

Citius Oncology Soars 35.06% on Distribution Deal - AInvest

Jul 16, 2025

Jul 16, 2025

Citius Oncology Soars 12.34% on Expanded Lymphir Distribution - AInvest

Jul 16, 2025

Jul 15, 2025

Citius Oncology stock rises after expanding LYMPHIR distribution network - Investing.com

Jul 15, 2025

Jul 15, 2025

What makes Citius Oncology Inc. stock price move sharplySecure Your Capital Strategy - Newser

Jul 15, 2025

Jul 15, 2025

Why Citius Oncology Inc. stock attracts strong analyst attentionEarly Breakout Tracker - Newser

Jul 15, 2025

Jul 15, 2025

Cencora (COR) Partners With Citius Oncology For Immunotherapy Distribution Expansion - simplywall.st

Jul 15, 2025

Jul 15, 2025

Citius Oncology Shares Climb Following Expansion of LYMPHIR Distribution Network - MSN

Jul 15, 2025